Massachusetts General Hospital: Leukemia trials

The registry lists 29 Leukemia studies with Massachusetts General Hospital as lead sponsor. 3 are open to participants now and 8 have results posted.

Phase 1 12Phase 2 8No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Addressing Cancer Care Equity With Social Determinants of Health Screening and Early InterventionRecruitingNCT07671209Not applicable
• I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm PatientsRecruitingNCT05842603Not applicable
• Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular TherapyRecruitingNCT05646576Not applicable
• Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AMLCompletedNCT02560025Phase 2Results posted
• Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive TherapiesCompletedNCT02410252Not applicableResults posted
• Busulfan/Clofarabine + Allogeneic Stem Cell TransplantationCompletedNCT01643668Phase 2Results posted
• Reduced Intensity Double Umbilical Cord Blood TransplantationCompletedNCT01408563Phase 2Results posted
• Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLLTerminatedNCT01173679Phase 2Results posted
• Treatment of Older Adults With Acute Lymphoblastic LeukemiaCompletedNCT00973752Phase 2Results posted
• Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantCompletedNCT00513474Phase 1Results posted
• Dasatinib in Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00438854Phase 2Results posted
• Psychological Mobile App for Patients With AMLTerminatedNCT05501171Not applicable
• Vaccine Responsiveness in Patients With Chronic Lymphocytic LeukemiaCompletedNCT05007860
• AZD6738 for Patients With Progressive MDS or CMMLActive, not recruitingNCT03770429Phase 1
• Psychological Intervention Mobile App for Patients With AMLCompletedNCT03372291Not applicable
• A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid LeukemiaCompletedNCT02975869Not applicable
• Volasertib Combined With Induction Chemotherapy in Acute Myeloid LeukemiaWithdrawnNCT02905994Phase 1
• MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of AgeCompletedNCT02582359Phase 1
• Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AMLTerminatedNCT02255162Phase 1
• Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older AdultsCompletedNCT02228772Phase 1
• Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01961765Phase 1
• Sulindac for Patients With AMLWithdrawnNCT01843179Phase 2
• Brentuximab Vedotin + Re-induction Chemotherapy for AMLCompletedNCT01830777Phase 1
• Alisertib for Acute Myeloid LeukemiaCompletedNCT01779843Phase 1
• Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood DisordersCompletedNCT01758042Not applicable
• Lenalidomide Plus Chemotherapy for AMLCompletedNCT01681537Phase 1
• Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLLCompletedNCT01400685Phase 1
• VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous LeukemiaCompletedNCT00505700Phase 1
• Study of Unrelated Cord Blood Transplantation Using Tacrolimus and SirolimusCompletedNCT00133367Phase 2